HistoSonics
Pre-clinicalHistoSonics® is developing a non-invasive, robotically assisted platform capable of destroying tissue at a sub-cellular level.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $137M
About
HistoSonics® is developing a non-invasive, robotically assisted platform capable of destroying tissue at a sub-cellular level.
Medical DevicesOncology
Funding History
3Total raised:$137M
Series C$85MJun 15, 2021
Series B$40MDec 15, 2019
Series A$12MOct 15, 2017